64 research outputs found
QA of intensity-modulated beams using dynamic MLC log files
To evaluate the utility of Dynalog file information for planar dose verification in IMRT QA, a program is developed to convert Dynalog file data to DMLC field files. For this study, five predefined fluencies are planned and delivered using Varian, Eclipse 3D planning system and 6MV photon beam of Varian, Clinac DMX linear accelerator. To measure planar dose distribution, Kodak, EDR2 films are exposed in similar setup as planning setup. Dynalog files are recorded for each delivery and converted into DMLC field files using in-house program. Delivered dose distributions are calculated using DMLC field files from Dynalog files. Planned, Measured and Delivered dose distributions are compared using gamma evaluation in Scanditronix, Omni Pro IMRT software. The Planned and Delivered planar dose distributions agree within 2% dose difference and 2 mm DTA. Measured dose distributions agree within 4% dose difference and 4 mm DTA with Planned dose distribution. Our results show Dynalog file as a promising tool for dynamic IMRT QA
Recommended from our members
Semen parameters among adolescent males undergoing fertility preservation in an international cohort
Recommended from our members
Testosterone deficiency in men with end stage renal disease and kidney transplantation: a narrative review
Testosterone deficiency is a prevalent condition that frequently affects individuals with end-stage renal disease (ESRD) and those who have undergone renal transplantation. While the etiology of this condition is complex, its implications in this population are far-reaching, impacting various domains such as endocrine profile, sexual and erectile function, bone mineral density (BMD), anemia, and graft survival following renal transplantation. Herein, we review the most recent literature exploring the pathophysiology of testosterone deficiency in ESRD and renal transplant patients, examining its diverse effects on this demographic, and assessing the advantages of testosterone replacement therapy (TRT). Existing evidence suggests that TRT is a safe intervention in ESRD and renal transplant patients, demonstrating improvements across multiple domains. Despite valuable insights from numerous studies, a critical need persists for larger, high-quality prospective studies to comprehensively grasp the nuances of TRT, especially in this vulnerable population. Proactive screening and treatment of testosterone deficiency may prove beneficial, emphasizing the urgency for further research in this area
- …